Logo

Merck KGaA Collaborates with Iktos for its Artificial Intelligence (AI) Technology

Share this

Merck KGaA Collaborates with Iktos for its Artificial Intelligence (AI) Technology

Shots:

  • Merck KGaA enters into an agreement with Iktos to develop therapies using Iktos’ AI technology for three drug discovery projects
  • The focus of the agreement is to develop and advance its drug discovery techniques with the usage of Iktos’ technology enabled with AI solutions in multiple therapy areas
  • Iktos' AI technology is based on deep generative models providing drug discovery techniques by designing virtual molecules for treating diseases- also used in image processing & automatic translation. On Dec’18- Merck also collaborated with Cyclica for its AI-augmented proteome screening- Ligand Express

Ref: PRNewswire | Image: Merck KGaA 

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions